Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p21
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 21/191)
Character Range: 9681867–9697116

sunitinib.
C4872               P4872          CN4872           Hydrocortisone                                                                                                                                                             Ulcerative colitis

                                                    Prednisolone

C4877               P4877          CN4877           Pamidronic acid                                                                                                                                                            Symptomatic Paget disease of bone

                                                    Risedronic acid

C4878               P4878          CN4878           Mesalazine                                                                                                                                                                 Acute episode of mild to moderate ulcerative proctitis

C4888               P4888          CN4888           Mesalazine                                                                                                                                                                 Acute episode of mild to moderate ulcerative colitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 4888

C4890               P4890          CN4890           Goserelin                                                                                                                                                                  Carcinoma of the prostate
                                                                                                                                                                                                                               The condition must be locally advanced (stage C).  or
                                                                                                                                                                                                                               The condition must be metastatic (stage D).
C4892               P4892          CN4892           Goserelin                                                                                                                                                                  Endometriosis
                                                                                                                                                                                                                               The condition must be visually proven; AND
                                                                                                                                                                                                                               The treatment must be for the short-term (up to 6 months).
C4893               P4893          CN4893           Hydrocortisone                                                                                                                                                             Proctitis

                                                    Prednisolone

C4895               P4895          CN4895           Goserelin and bicalutamide                                                                                                                                                 Carcinoma of the prostate
                                                                                                                                                                                                                               The condition must be metastatic (stage D); AND
                                                    Leuprorelin and bicalutamide                                                                                                                                               Patient must require a combination of an antiandrogen and a GnRH (LH-RH) agonist.

C4897               P4897          CN4897           Temozolomide                                                                                                                                                               Glioblastoma multiforme
                                                                                                                                                                                                                               Patient must be undergoing concomitant radiotherapy.
C4898               P4898          CN4898           Adapalene with benzoyl peroxide                                                                                                                                            Severe acne vulgaris
                                                                                                                                                                                                                               The treatment must be maintenance therapy.
C4899               P4899          CN4899           Hydrocortisone                                                                                                                                                             Corticosteroid-responsive dermatoses

C4902               P4902          CN4902           Methadone                                                                                                                                                                  Chronic severe disabling pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures
                                                                                                                                                                                                                               Initial treatment, for up to 3 months
                                                                                                                                                                                                                               Patient must be receiving palliative care; AND
                                                                                                                                                                                                                               The condition must be unresponsive to non-opioid analgesics.
C4907               P4907          CN4907           Celecoxib                                                                                                                                                                  Rheumatoid arthritis
                                                                                                                                                                                                                               The treatment must be for symptomatic treatment.
                                                    Meloxicam

C4908               P4908          CN4908           Cetuximab                                                                                                                                                                  Metastatic colorectal cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 4908
                                                                                                                                                                                                                               Initial treatment
                                                                                                                                                                                                                               Patient must have RAS wild-type metastatic colorectal cancer; AND
                                                                                                                                                                                                                               Patient must have a WHO performance status of 0 or 1; AND
                                                                                                                                                                                                                               The condition must be previously untreated; AND
                                                                                                                                                                                                                               The treatment must be in combination with first-line chemotherapy; AND
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised anti-EGFR antibody therapy for this condition.
C4909               P4909          CN4909           Adrenaline (epinephrine)                                                                                                                                                   Acute allergic reaction with anaphylaxis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures
                                                                                                                                                                                                                               Initial sole PBS-subsidised supply for anticipated emergency treatment
                                                                                                                                                                                                                               Patient must have been assessed to be at significant risk of anaphylaxis by, or in consultation with a clinical immunologist.  or
                                                                                                                                                                                                                               Patient must have been assessed to be at significant risk of anaphylaxis by, or in consultation with an allergist.  or
                                                                                                                                                                                                                               Patient must have been assessed to be at significant risk of anaphylaxis by, or in consultation with a paediatrician.  or
                                                                                                                                                                                                                               Patient must have been assessed to be at significant risk of anaphylaxis by, or in consultation with a respiratory physician.
                                                                                                                                                                                                                               The name of the specialist consulted must be provided at the time of application for initial supply.
C4910               P4910          CN4910           Enoxaparin                                                                                                                                                                 Haemodialysis

C4912               P4912          CN4912           Cetuximab                                                                                                                                                                  Metastatic colorectal cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 4912
                                                                                                                                                                                                                               Continuing treatment
                                                                                                                                                                                                                               Patient must have received an initial authority prescription for this drug